| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 327,089 | 352,186 | 325,850 | 430,411 | | Cost of Revenue | 438,673 | 197,074 | 180,192 | 227,900 | | | Gross Profit | (111,584) | 155,112 | 145,658 | 202,511 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 18,879 | 11,235 | 12,245 | 4,735 | | Non Recurring | 280,480 | 22,371 | (214) | 33,735 | | Others |
-
| 86,662 | 80,016 | 83,217 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (236,555) | 34,844 | 53,611 | 80,824 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (12,478) | 455 | 33,185 | (13,573) | | Earnings Before Interest And Taxes | (254,379) | 37,761 | 89,323 | 72,857 | | Interest Expense | 57,673 | 52,005 | 52,068 | 51,491 | | Income Before Tax | (312,052) | (14,244) | 37,255 | 21,366 | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| (1,027) | | | | Net Income From Continuing Ops | (314,105) | (14,244) | 37,255 | 21,366 | | | Non-recurring Events | | Discontinued Operations | (46) | (854) | 5,332 | 4,693 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (314,151) | (15,098) | 42,587 | 26,059 | | Preferred Stock And Other Adjustments | (18,784) | (16,965) | (19,340) | (4,342) | | | Net Income Applicable To Common Shares | ($321,352) | ($32,063) | $23,247 | $21,717 |
|
0.51% Nasdaq 0.00%
Income Statement
